| Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix … M Roach III, G Hanks, H Thames Jr, P Schellhammer, WU Shipley, ... International Journal of Radiation Oncology* Biology* Physics 65 (4), 965-974, 2006 | 3048 | 2006 |
| Quality of life and satisfaction with outcome among prostate-cancer survivors MG Sanda, RL Dunn, J Michalski, HM Sandler, L Northouse, L Hembroff, ... New England Journal of Medicine 358 (12), 1250-1261, 2008 | 2671 | 2008 |
| Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer JT Wei, RL Dunn, MS Litwin, HM Sandler, MG Sanda Urology 56 (6), 899-905, 2000 | 1636 | 2000 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (3), 683-690, 2018 | 1183* | 2018 |
| Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ... Journal of Clinical Oncology 25 (15), 2035-2041, 2007 | 1087 | 2007 |
| Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the … GE Hanks, TF Pajak, A Porter, D Grignon, H Brereton, V Venkatesan, ... Journal of Clinical Oncology 21 (21), 3972-3978, 2003 | 866 | 2003 |
| Radiotherapy and short-term androgen deprivation for localized prostate cancer CU Jones, D Hunt, DG McGowan, MB Amin, MP Chetner, DW Bruner, ... New England Journal of Medicine 365 (2), 107-118, 2011 | 820 | 2011 |
| Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer EM Horwitz, K Bae, GE Hanks, A Porter, DJ Grignon, HD Brereton, ... Journal of Clinical Oncology 26 (15), 2497-2504, 2008 | 800 | 2008 |
| Radiation with or without antiandrogen therapy in recurrent prostate cancer WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ... New England Journal of Medicine 376 (5), 417-428, 2017 | 687 | 2017 |
| Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer WR Lee, JJ Dignam, MB Amin, DW Bruner, D Low, GP Swanson, ... Journal of Clinical Oncology 34 (20), 2325-2332, 2016 | 644 | 2016 |
| Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas HA Gay, HJ Barthold, E O’Meara, WR Bosch, I El Naqa, R Al-Lozi, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), e353-e362, 2012 | 568 | 2012 |
| Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy JL Chan, SW Lee, BA Fraass, DP Normolle, HS Greenberg, LR Junck, ... Journal of clinical oncology 20 (6), 1635-1642, 2002 | 564 | 2002 |
| Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer JT Wei, RL Dunn, HM Sandler, PW McLaughlin, JE Montie, MS Litwin, ... Journal of Clinical Oncology 20 (2), 557-566, 2002 | 554 | 2002 |
| Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis WU Shipley, HD Thames, HM Sandler, GE Hanks, AL Zietman, CA Perez, ... Jama 281 (17), 1598-1604, 1999 | 548 | 1999 |
| Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer TR Willoughby, PA Kupelian, J Pouliot, K Shinohara, M Aubin, M Roach III, ... International Journal of Radiation Oncology* Biology* Physics 65 (2), 528-534, 2006 | 514 | 2006 |
| Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy DC Miller, MG Sanda, RL Dunn, JE Montie, H Pimentel, HM Sandler, ... Journal of Clinical Oncology 23 (12), 2772-2780, 2005 | 470 | 2005 |
| Prostate cancer–major changes in the American Joint Committee on Cancer eighth edition cancer staging manual MK Buyyounouski, PL Choyke, JK McKenney, O Sartor, HM Sandler, ... CA: a cancer journal for clinicians 67 (3), 245-253, 2017 | 447 | 2017 |
| Merkel cell carcinoma: critical review with guidelines for multidisciplinary management CK Bichakjian, L Lowe, CD Lao, HM Sandler, CR Bradford, TM Johnson, ... Cancer 110 (1), 1-12, 2007 | 430 | 2007 |
| Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ... Journal of Clinical Oncology 35 (27), 3097-3104, 2017 | 429 | 2017 |
| Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer JM Michalski, C Lawton, I El Naqa, M Ritter, E O'Meara, MJ Seider, ... International Journal of Radiation Oncology* Biology* Physics 76 (2), 361-368, 2010 | 428 | 2010 |
Martin G SandaProfessor and Chairman of Urology, Emory University School of MedicineVerified email at emory.edu
